Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Progyny Inc

PGNY
Current price
21.44 USD +0.22 USD (+1.04%)
Last closed 21.43 USD
ISIN US74340E1038
Sector Healthcare
Industry Healthcare Plans
Exchange NASDAQ
Capitalization 1 836 730 496 USD
Yield for 12 month -35.15 %
1Y
3Y
5Y
10Y
15Y
PGNY
21.11.2021 - 28.11.2021

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Address: 1359 Broadway, New York, NY, United States, 10018

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26.75 USD

P/E ratio

37.61

Dividend Yield

Current Year

+1 167 221 000 USD

Last Year

+1 088 598 000 USD

Current Quarter

+298 431 000 USD

Last Quarter

+286 625 000 USD

Current Year

+253 363 000 USD

Last Year

+238 799 000 USD

Current Quarter

+63 432 000 USD

Last Quarter

+59 244 000 USD

Key Figures PGNY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 70 630 000 USD
Operating Margin TTM 5.29 %
Price to Earnings 37.61
Return On Assets TTM 6.18 %
PEG Ratio
Return On Equity TTM 11.14 %
Wall Street Target Price 26.75 USD
Revenue TTM 1 167 220 992 USD
Book Value 4.98 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.60 %
Dividend Yield
Gross Profit TTM 253 363 008 USD
Earnings per share 0.57 USD
Diluted Eps TTM 0.57 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -17.00 %
Profit Margin 4.66 %

Dividend Analytics PGNY

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PGNY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation PGNY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 37.61
Forward PE 13.93
Enterprise Value Revenue 1.39
Price Sales TTM 1.57
Enterprise Value EBITDA 23.05
Price Book MRQ 4.35

Financials PGNY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PGNY

For 52 weeks

13.39 USD 33.84 USD
50 Day MA 21.96 USD
Shares Short Prior Month 10 173 394
200 Day MA 20.41 USD
Short Ratio 3.16
Shares Short 6 447 898
Short Percent 9.56 %